Stocks · Health care · Pharmaceutical Preparations

Acrivon Therapeutics, Inc.

ACRV Clue Score43

United States Fiscal year ends December CIK 0001781174 Results filed 12 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

17 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Peter Blume-Jensen

President and CEO

$82.12K (1)

$34.41K (3)

+$47.71K

2,615,911

6.10%

$4.81M

−4.5%

Eric Devroe

Chief Operating Officer

$17.22K (1)

$1.21K (1)

+$16.00K

146,349

0.3415%

$269.28K

+113.7%

Adam D. Levy

Chief Financial Officer

$15.00K (1)

$1.79K (1)

+$13.21K

66,008

0.1540%

$121.45K

+395.7%

Mary Miller

Chief Legal Officer

—

$2.91K (4)

−$2.91K

81,202

0.1895%

$149.41K

+113.0%

Erick Gamelin

Chief Development Officer

—

$804.00 (1)

−$804.00

52,592

0.1227%

$96.77K

+202.9%

Katharine Peterson

Chief Accounting Officer

—

$203.01 (1)

−$203.01

18,033

0.0421%

$33.18K

+289.1%

Perceptive Advisors LLC entity

10% owner

—

—

—

3,104,139

7.24%

$5.71M

−42.1%

Mansoor Raza Mirza

Chief Medical Officer

—

—

—

38,817

0.0906%

$71.42K

—

Michaela Levin

Chief Business Officer

—

—

—

30,000

0.0700%

$55.20K

—

Rasmus Holm-Jorgensen

Chief Financial Officer

—

—

—

26,088

0.0609%

$48.00K

−3.0%

Ra Capital Management, L.p. entity

Director

—

—

—

9,366

0.0219%

$17.23K

—

Derek DiRocco

Director

—

—

—

9,366

0.0219%

$17.23K

—

Santhosh Palani

Director

—

—

—

9,366

0.0219%

$17.23K

—

Ivana Magovcevic-Liebisch

Director

—

—

—

9,366

0.0219%

$17.23K

—

Michael John Tomsicek

Director

—

—

—

9,366

0.0219%

$17.23K

—

Sharon Shacham

Director

—

—

—

9,366

0.0219%

$17.23K

—

Charles M Baum

Director

—

—

—

9,366

0.0219%

$17.23K

—